Iron sulphate dose
Pro Research Analysisby 
Searched over 200M research papers
Iron Sulphate Dosage in Various Populations
Iron Sulphate Dosage in Pregnant Women
Daily vs. Twice Daily Dosing
Research comparing daily and twice daily doses of ferrous sulphate in pregnant women has shown that both regimens are effective in preventing iron deficiency anemia. A study involving 182 pregnant women found that a once daily dose of 65 mg elemental iron was as effective as a twice daily dose of 130 mg elemental iron in maintaining hemoglobin levels. However, the twice daily regimen resulted in significantly more side effects, suggesting that a once daily dose may be preferable for better compliance and fewer adverse effects.
Intravenous vs. Oral Iron Supplementation
In cases of postpartum anemia, intravenous iron sucrose followed by oral ferrous sulphate has been shown to replenish iron stores more rapidly and improve fatigue scores compared to oral iron alone. A study involving 128 postpartum women demonstrated that intravenous iron sucrose led to significantly higher serum ferritin levels after four weeks, although hemoglobin levels were similar between the groups at 8 and 12 weeks. Another study comparing intravenous ferric carboxymaltose, intravenous iron polymaltose, and daily oral ferrous sulphate found that intravenous iron was more effective in rapidly increasing hemoglobin and ferritin levels, with better compliance and fewer missed doses compared to oral iron.
Iron Sulphate Dosage in Non-Pregnant Women
Prolonged-Release Iron Supplementation
A study on the pharmacokinetics of a single oral dose of prolonged-release ferrous sulphate (Tardyferon®) in non-pregnant women with iron deficiency anemia showed that the formulation maintained elevated serum iron levels for up to 12 hours post-dosing. This suggests that prolonged-release formulations can provide a sustained release of iron, potentially improving iron absorption and reducing gastrointestinal side effects.
Iron Supplementation for Unexplained Fatigue
Iron supplementation has also been studied in non-anemic women with unexplained fatigue. A randomized controlled trial found that women with low or borderline serum ferritin levels experienced a significant reduction in fatigue after four weeks of daily supplementation with 80 mg of elemental iron compared to a placebo. This indicates that even in the absence of anemia, iron supplementation can be beneficial for women experiencing fatigue, particularly those with low ferritin levels.
Iron Sulphate Dosage in Patients with Chronic Conditions
Renal Insufficiency
In patients with progressive renal insufficiency, both oral and intravenous iron supplementation have been shown to be effective when used alongside erythropoietin. A study involving 45 patients found no significant differences in hemoglobin response or erythropoietin dose requirements between those receiving oral ferrous sulphate and those receiving intravenous iron sucrose. However, intravenous iron resulted in higher serum ferritin levels, suggesting better iron store replenishment.
Conclusion
The optimal dosage and route of iron sulphate supplementation can vary depending on the population and specific health conditions. For pregnant women, a once daily dose of 65 mg elemental iron is effective and better tolerated than a twice daily regimen. Intravenous iron supplementation can provide rapid replenishment of iron stores and improve compliance in both pregnant and postpartum women. In non-pregnant women with iron deficiency anemia or unexplained fatigue, prolonged-release formulations and daily supplementation can be beneficial. For patients with chronic conditions like renal insufficiency, both oral and intravenous iron are effective, with intravenous iron offering better iron store replenishment.
Sources and full results
Most relevant research papers on this topic